Outlook Therapeutics
(NASDAQ) OTLK
Outlook Therapeutics Financials at a Glance
Market Cap
$17.61M
Revenue (TTM)
$205.53K
Net Income (TTM)
$102.86M
EPS (TTM)
$-1.09
P/E Ratio
-0.19
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$0.21
Volume
61,296
Open
$0.22
Price
$0.21
Volume
61,296
Open
$0.22
Previous Close
$0.21
Daily Range
$0.20 - $0.22
52-Week Range
$0.16 - $3.39
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$0.21
Volume
61,296
Open
$0.22
Previous Close
$0.21
Daily Range
$0.20 - $0.22
52-Week Range
$0.16 - $3.39
OTLK News
OTLK: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Outlook Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
23
CEO
Robert Charles Jahr, MBA
Website
www.outlooktherapeutics.comHeadquarters
Iselin, NJ 08852, US
OTLK Financials
Key Financial Metrics (TTM)
Gross Margin
-6%
Operating Margin
-287%
Net Income Margin
-500%
Return on Equity
0%
Return on Capital
2%
Return on Assets
-6%
Earnings Yield
-5.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$17.61M
Shares Outstanding
84.61M
Volume
61.30K
Short Interest
0.00%
Avg. Volume
5.59M
Financials (TTM)
Gross Profit
$657.21K
Operating Income
$67.06M
EBITDA
$63.58M
Operating Cash Flow
$51.83T
Capital Expenditure
$3.00
Free Cash Flow
$51.83T
Cash & ST Invst.
$8.08T
Total Debt
$247.70B
Outlook Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.21M
N/A
Gross Profit
$1.24M
-4198.5%
Gross Margin
1.02%
N/A
Market Cap
$17.61M
N/A
Market Cap/Employee
$765.57K
N/A
Employees
23
N/A
Net Income
$23.06M
-232.7%
EBITDA
$13.48M
+37.5%
Quarterly Fundamentals
Net Cash
$28.22M
-11.4%
Accounts Receivable
$114.61K
N/A
Inventory
$0.00
-100.0%
Long Term Debt
$171.99K
-26.2%
Short Term Debt
$36.72M
+19.2%
Return on Assets
-5.64%
N/A
Return on Invested Capital
1.91%
N/A
Free Cash Flow
$14.94T
-136214495.4%
Operating Cash Flow
$14.94T
-136214495.4%